STAT1 and endometrioid adenocarcinoma: Patients with serous ovarian cancer expressed lower levels of STAT1 mRNA, while higher levels of STAT 2, 5A, and 5B mRNA had longer PFS but had no effect on patients with endometrioid carcinoma.